Icon Pharmaceuticals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
as on 11-06-2024
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About Icon Pharmaceuticals Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
- CIN/LLPIN/FCRN
AAX-4531
- Incorporation Date
18 Jun 2021
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Mumbai
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Icon Pharmaceuticals Llp?
Designated Partners(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvindkumar Singh  | Designated Partner | 18-Jun-2021 | Current |
| Vinaykumar Pandey | Designated Partner | 18-Jun-2021 | Current |
| Amit Tiwari | Designated Partner | 18-Jun-2021 | Current |
| Mohd Pathan | Designated Partner | 18-Jun-2021 | Current |
| Gyanendra Singh | Designated Partner | 18-Jun-2021 | Current |
| Farhan Shekhani | Designated Partner | 04-Dec-2021 | Current |
Financial Performance of Icon Pharmaceuticals Llp.
Enhance accessibility to Icon Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Icon Pharmaceuticals Llp?
Unlock access to Icon Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
United Forever LlpActive 2 years 10 monthsArvindkumar Singh, Vinaykumar Pandey and 3 more are mutual person
- Playfulness Builders & Developers Private LimitedActive 3 months 21 days
Arvindkumar Singh, Vinaykumar Pandey and 1 more are mutual person
- Affability Builders & Developers Private LimitedActive 3 months 22 days
Arvindkumar Singh, Vinaykumar Pandey and 1 more are mutual person
- Friendliness Builders & Developers Private LimitedActive 3 months 22 days
Arvindkumar Singh, Vinaykumar Pandey and 1 more are mutual person
- Urbanhive Builders & Developers Private LimitedActive 3 months 19 days
Arvindkumar Singh, Vinaykumar Pandey and 1 more are mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Icon Pharmaceuticals Llp?
Unlock and access historical data on people associated with Icon Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Icon Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Icon Pharmaceuticals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
